DC-DC Converter Market To Garner US$ 5 Billion  By The End Of 2025

Persistence Market Research’s exclusive report on the global DC-DC converters market offers key insights on how the adoption of DC-DC converters will incur traction in the foreseeable future. The report has addressed several factors influencing the expansion of the global DC-DC converters market for the assessment period, 2017-2025. During this period, the global DC-DC converters market is forecasted to expand steadily at a CAGR of 5%. By the end of 2025, DC-DC converters worth over US$ 5 billion are expected to be sold across the globe. Increasing integration of power conversion modules in electronics devices, growing non-uniformity in DC power distribution, and advancements in electricity grids are observed to drive the growth of the global DC-DC converters market during the forecast period.

Continuous Tracking of DC-DC Converters: Key Challenge for Manufacturers

The study has profiled leading manufacturers of DC-DC converters, which include General Electric, Texas Instruments, Inc., Ericsson, Delta Electronics Inc., Murata Manufacturing Co. Ltd., Vicor Corporation, Bel Fuse Inc., ON Semiconductor, Cosel Co. Ltd, FUJITSU, Infineon technologies AG, Mornsun Guangzhou Science & Technology Co. Ltd, ST Microelectronics, PICO Electronics, and Artesyn Embedded Technologies. These companies are anticipated to be active in expansion of the global DC-DC converter market throughout the forecast period. However, catering to the end-use requirements, DC-DC converters available in the market are being compelled to undergo transformation. The need for continuous DC-DC conversion tracking has gained traction in the past few years.

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/dc-dc-converter-market/toc 

With expanding electricity grids and increasing incidence of power loss, end-users of DC-DC converters are demanding the enabling of continuous tracking. In 2017 and beyond, several manufacturers of DC-DC converters are expected to extend the abilities of their products by including continuous tracking. With continuous tracking, DC-DC converters can be effectively monitored and incidences of power overload, power outage or power loss can be avoided.

In the view of evolving applications, manufacturers are opting for high-performance designs in development of DC-DC converters. For enabling these converters the ability to continuously track external voltage references with current source, sink capability and close tolerances is becoming a concerning challenge. Manufacturers must allow the use of external reference source for facilitating continuous tracking of DC-DC converters. However, the load-current changes will continue to create errors in tracking abilities and the static tracking performance of tracking regulators will change adversely.

Report overview @ https://www.persistencemarketresearch.com/market-research/dc-dc-converter-market.asp 

IT & Telecom to Represent Largest End-user for DC-DC Converters

According to the report findings, the global DC-DC converter market is anticipated to register largest end-use applications in the IT and telecommunications sector. During the forecast period, revenues procured from global sales of DC-DC converters in IT & telecom industry are expected to surge at a CAGR of 5.7%. The report also projects that the demand for DC-DC converters will gain traction in the healthcare and automotive industry. In 2016, more than US$ 760 million worth of DC-DC converters were sold across automotive applications in the world. Between 2017 and 2025, the application of DC-DC converters in consumer electronics manufacturing is expected to register 1.5X times growth in revenues.

Request to sample report @ https://www.persistencemarketresearch.com/samples/19360 

Besides the end-use applications, the report has analyzed the global DC-DC converter market on the basis of output power, output number, input voltage, form and products. The study has also developed a regional analysis on the expansion of the global DC-DC converter market. By 2025, the Asia-Pacific region is likely to dominate the global DC-DC converter market, pertaining to the growing telecommunication businesses in the region. During the forecast period, the Asia-Pacific DC-DC converter market is likely to register a value CAGR of 5.8%, reflecting fastest revenue growth compared to other regions.

Smart Ticketing Market To Reach US$ 5,000 Million  By The End Of 2022

Persistence Market Research (PMR) in its latest report reveals that the global smart ticketing market is set to exhibit a robust CAGR of 14.5% during the forecast period (2017-2022). The report finds that smart ticketing is becoming rampant in technology-driven cities. Growing pressure on transit systems is expected to boost the adoption of smart ticketing technology in the forthcoming years. Public transport systems, especially in developed countries are promoting smart ticketing to reduce paper wastage and improve the passenger experience. Smart ticketing is becoming a major force in the transportation sector while its application continues to increase in sectors such as healthcare, sports & entertainments and banking among others.

Owing to benefits of cost, greater efficiency, accuracy and security, preference for smart ticketing is increasing among both end-users and service providers. Smart tickets are effectively addressing the issues of mobility and ticketing discrepancies. Increasing urgency of streamlining ticket booking and issuing procedures is driving the demand for smart ticketing solutions. Digitization of ticket booking platforms and integration of chip-based and barcode technologies (RFID, NFC, QR, etc.) is facilitating a quick adoption of smart ticketing systems. Moreover, ongoing smart city initiatives and robust infrastructural development in emerging countries such as China, Brazil and India expected to reflect favorably on the global market for smart ticketing during the forecast period. Improvements in wireless networks and expanding user bases of smart technologies is likely to create market opportunities for players. Deployment of open payment systems in hospitals, railway stations, airports and stadiums is provisioning broader application of smart ticketing. However, downtimes issues and lack of awareness among end-user regarding smart ticketing technology is impacting the adoption rate to an extent.

North America at the Forefront of the Global Market for Smart Ticketing 

In terms of revenue, North America is expected to dominate the global market for smart ticketing during the forecast period. The market in the region is projected to surge at a double-digit CAGR from 2017 to 2022 and reach a valuation in excess of US$ 2,400 Mn. This is primarily attributed to factors such as the presence of a large number of technology companies with expertise in smart ticketing solution and growing demand for solutions that can streamline ticketing procedures. Meanwhile, Europe is estimated to account for more than one-fourth revenue share of the global market by 2017-end. 

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/smart-ticketing-market/toc 

POS Terminals - a Leading Segment Over 2022

On the basis of components, the POS terminals segment is expected to post impressive year-over-year growth throughout the assessment period. In terms of revenue, the segment currently commands for nearly 28% share of the market and expected to surpass a valuation of US$ 1,500 by 2022-end, reflecting a strong CAGR. The POS terminals segment is set to grow by US$ 142 Mn annually over the course of the forecast period.

Wi-Fi Connectivity Will Remain Important For Facilitating Smart Ticketing

By connectivity, the Wi-Fi segment is expected to remain highly attractive over the next couple of years. By 2017-end, the segment is estimated to represent over one-fourth revenue share of the market. The Wi-Fi segment is anticipated to reach a market valuation of US$ 1,700 Mn toward the end of 2022, exhibiting a robust growth rate.

Report overview @ https://www.persistencemarketresearch.com/market-research/smart-ticketing-market.asp 

Transportation Sector Will continue to be the Larger End-Use of Smart Ticketing Over 2022

On the basis of end-user, the transportation segment will continue to hold the top spot during the forecast period. Smart ticketing is witnessing significant success in the transportation sector as well as helping change passengers’ outlook towards public transit system. The transportation segment is estimated to surpass a valuation of US$ 1,800 Mn by 2022 end.

Request to sample report @ https://www.persistencemarketresearch.com/samples/19954 

Global Smart Ticketing Market: Key Players

PMR in its report has profiled some of the leading companies operating in the global market for smart ticketing which include Xerox Corporation, Cubic Corporation, Gemalto NV, Rambus, Confidex Ltd., NXP Semiconductors, CPI Card Group, Infineon Technologies AG, HID Global Corporation, and Giesecke & Devrient GmbH.

Deep Learning Market To Garner US$ 66 Billion By The End Of 2027

A new report has recently been published by Persistence Market Research to present a comprehensive analysis of the global deep learning market. Titled ‘Deep Learning Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2027),’ this report is an in-depth study of the concept of deep learning and the performance of the global market for deep learning across key end use industry sectors across seven key geographies. The report carefully analyzes the different factors responsible for impacting market revenue growth over a 10 year assessment period from 2017 to 2027 and presents insights on the market growth and performance to investors and other key market stakeholders.

Global Deep Learning Market: Revenue Forecast & Market Dynamics Analysis

According to Persistence Market Research forecasts, the global deep learning market is estimated to be valued at US$ 4,841.2 Mn by the end of 2017 and this is projected to increase to a whopping US$ 261,113.0 Mn by the end of the forecast period in 2027. This denotes an exponential compound annual growth rate of 49.0% recorded during the period of forecast. This growth can be attributed to a need for better processing hardware, increase in research and development activities in some markets around the globe, and rapid adoption of cloud based technologies across the globe.

Report overview @ https://www.persistencemarketresearch.com/market-research/deep-learning-market.asp 

However, deep learning requires high performance hardware that is not easily available. Cost is another limiting factor. Also, several enterprises prefer the traditional route over hyperparameter optimization. These factors are expected to restrict revenue growth of the deep learning market in the coming decade. Utilization of deep learning technology in smartphones and medical image analysis for diagnosis of chronic diseases such as cancer; and in virtual patient assistance is trending the global deep learning market.

Global Deep Learning Market: Forecast Analysis by End Use Industry

The global deep learning market is segmented on the basis of end use industry into Manufacturing, Healthcare, Media & Entertainment, Security, Finance, and Others. Finance is the largest segment, expected to hold more than 40% value share of the global deep learning market by 2027. Finance is also expected to be the fastest growing end use industry segment, with a CAGR of 60.1% during the forecast period. In terms of value, the Finance segment is projected to be the most attractive in the global deep learning market during the period of study.

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/deep-learning-market/toc 

Global Deep Learning Market: Forecast Analysis by Region

Seven regional markets are assessed in this report on the global deep learning market. These key geographies are North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and the Middle East and Africa. North America is the leading regional market for deep learning, expected to hold 42.4% share of the global market by 2027 end. APEJ is the second largest regional market, with an estimated value share of just under 26% by the end of the forecast period in 2027. In terms of value, North America is projected to be the most attractive region in the global deep learning market during the period of study.

Request to sample report @ https://www.persistencemarketresearch.com/samples/20281 

Global Deep Learning Market: Key Player Insights

The report profiles some of the top companies in the global deep learning market such as Google Inc., Microsoft Corp., IBM Corporation, Facebook Inc., Qualcomm Technologies, Inc., NVIDIA Corp., Amazon.com, Inc., Intel Corporation, Clarifai, Inc., and Deep Instinct Ltd. Key players are looking to adopt a strategy of moving to different sectors with their products from the deep learning algorithm to enhance revenue share in the global market. Companies in the global deep learning market are also focusing on improving their artificial intelligence capabilities and the deep learning service portfolio across multiple industry sectors like electronics retail.

Bouillon Market To Garner US$ 10 Billion  By The End Of 2025

Persistence Market Research has analyzed various facets of the bouillon market from a global standpoint and has skilfully presented them in its new research publication titled “Bouillon Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. The extensive bouillon market research report covers various trends, opportunities, drivers and restraints influencing the growth of the global bouillon market along with regional analysis, competitive scenario and forecasts. This analysis focuses on each segment and sub-segment of the global market based on which analysts have given their opinions regarding various market dynamics.

Global Bouillon Market: Forecast Highlights

According to the analysis on bouillon market by Persistence Market Research, the global market is expected to reach a valuation of more than US$ 10 Bn by the end of the year of assessment from a value of around US$ 7.1 Bn in 2017. The global bouillon market is projected to expand at a moderate rate to reflect a CAGR of 4.5% during the period of assessment.

Report overview @ https://www.persistencemarketresearch.com/market-research/bouillon-stock-cubes-market.asp 

Global Bouillon Market: Segmentation Analysis

The global bouillon market is segmented on the basis of product type, form, distribution channel and region.

By region, North America is expected to show high market attractiveness and is anticipated to dominate the global market. The bouillon market in this region is estimated to reach a value of more than US$ 3 Bn by the end of the year of assessment.

By product type, meat segment is the largest and is estimated to be valued at US$ 6.2 Bn by 2025 end, but is expected to grow at a comparatively slow rate during the forecast period. Vegetable segment in this category is projected to grow at the fastest pace to register a CAGR of 5.5% during the period of assessment.

Request to sample report @ https://www.persistencemarketresearch.com/samples/13312 

By form, powder segment is the fastest growing segment owing to increased preference of this form. It is expected to grow at a high value CAGR of 5.9% throughout the period of forecast. The cubes segment is the largest with a high market share and is likely to lead the global market in the years to follow.

By distribution channel, supermarket/hypermarkets segment is estimated to hold a high market share. Also, independent grocery stores are expected to exhibit a high CAGR of 6.3% during the forecast period.

Global Bouillon Market: Dynamics Influencing Market Expansion

Rising awareness of fortified foods, increasing per capita expenditure, increasing consumption of a variety of bouillon products, increase in demand for vegan food products, improved retail format, increasing awareness of consumers, awareness based marketing, rise of e-commerce making the market highly transparent, good supply chain and private label products, rising demand for clean label products, increasing research and development expenditure, growing urbanization and increasing government support for food research and innovation are boosting the growth of the global bouillon market. Factors such as availability of substitutes, high price and lack of skilled labor are restricting the growth of the global bouillon market.

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/bouillon-stock-cubes-market/toc 

Global Bouillon Market: Competitive Analysis

The research report on global bouillon market includes company profiles of key players involved in the market. Major companies such as NESTLE S.A., THE UNILEVER GROUP, International Dehydrated Foods, Inc., HENNINGSEN FOODS, McCormick & Company, Inc., Anhui Goodday Food Co., Ltd., Goya Foods Inc., Hormel Foosd Corporation, The Kraft Heinz Company, Southeastern Mills Inc., Integrative Flavors, Proliver Bvba, MORGA AG, GB Foods, Massel Pty., Ltd., Edwards and Sons Trading Company Inc., and Major Products Inc., are analyzed and profiled in this extensive research report.

Intelligent Vending Machines Market To Garner US$ 15 Billion  By The End Of 2025

A new research report is published by Persistence Market Research titled ‘Intelligent Vending Machines Market: Global Industry Analysis 2012–2016 and Forecast 2017–2025’. The report gives a clear overview of the global intelligent vending machines market along with price analysis, Y-o-Y growth, trends that are governing the market, drivers that are driving the market growth and also restraints that are limiting the market growth. According to the forecast by PMR, the global intelligent vending machines market is expected to project a market value of over US$ 5,000 Mn in 2017 reaching a value of over US$ 15 Bn in 2025. It is anticipated to grow at a CAGR of 15.3% during the forecast period.

Intelligent vending machines refer to the new type of vending machines that dispense food and drinks. These machines have large LCD screens on the front doors that are used for interaction with consumers. It also features different advancements for payment options. The new technologies that are offered with smart vending machines are Near Field Communication, Telemetry Systems, Voice Recognition, Digital Signage, ERP etc. Its smart payment options include payment through E-Wallets, Credit Cards, Debit Cards, NFC and others, which reduce consumers’ efforts to carry money.

The research report by PMR segments the global intelligent vending machines market into various segments based on different parameters.

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/intelligent-vending-machines-market/toc 

On the basis of product type, hot drinks is expected to be the most lucrative segment of the market, as the demand for hot tea and coffee machines at corporate offices is increasing. It is expected to project a market value of over US$ 1,480 Mn in 2017. The market of soft drinks is also expected to register a CAGR of 16.3% during the forecast period.

On the basis of end use, the market is dominated by the corporate commercial areas segment with a market value of around US$ 1,340 Mn in 2017 and is anticipated to grow at a CAGR of 17.8%. It is followed by the mall and retail stores segment, which is anticipated to show growth at a steady CAGR of 15.8%.

Request to sample report @ https://www.persistencemarketresearch.com/samples/20221 

On the basis of region, North America is the most attractive region that is estimated to hold the maximum market value of over US$ 1,600 Mn in 2017, expected to reach a market value of over US$ 5,000 Mn in 2025, growing at a CAGR of 15.4% during the forecast period.

This comprehensive research report includes a section that briefs the profiles of key players in the global intelligent vending machines market. It includes information on the current market developments and also future growth and expansion strategies. Some of the key players included in the report are N&W Global Vending S.p.A., Seaga, FAS INTERNATIONAL S.P.A., Rhea Vendors Group Spa, Azkoyen Group, Sielaff GmbH & Co. KG, Automated Merchandising Systems Inc., BIANCHI INDUSTRY SPA, Jofemar Corporation, Continental Vending Inc., AUTOMATIC VENDING SPECIALISTS etc.

Get full report now @ https://www.persistencemarketresearch.com/checkout/20221 

ePRO, E-Patient Diaries and eCOA Market To Garner US$ 2,986 Million  By The End Of 2025

Technological advancements in the healthcare sector have resulted in the adoption of new technologies for clinical trials. Some of these technologies include Electronic Clinical Outcome Assessments (eCOA) and Electronic Patient Diaries (E-Patient Diaries). eCOA uses advanced mobile technology such as smartphones, tablets, and personal computers to allow patients, clinicians, and their caregivers to directly report outcomes. eCOA generates highly accurate data that allows for a better understanding of the patient experience in clinical trials. Electronic patient diaries is an electronic diary or tool that is used in clinical trials or in disease treatment to either evaluate the patient's condition or to measure treatment compliance. A new research report by Persistence Market Research provides an overview of the ePRO, e-patient diaries and eCOA market. The report is titled ‘ePRO, E-Patient Diaries and eCOA Market:Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’. According to the research forecast in the report, the global market is expected hold a value of just under US$ 958 Mn in 2017, and is expected to reach a value of about US$ 2,986 Mn in 2025, growing at an exponential CAGR of 15.3%.

Global ePRO, E-Patient Diaries and eCOA Market: Dynamics

There are a lot of factors that have helped boost revenue growth of the global ePRO, e-patient diaries and eCOA market. One of the main factors is the boom in technological advancements in the healthcare sector and adoption of mobile technologies. The use of electronic devices to collect clinical report outcomes has helped the market grow at a higher pace.

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/epro-epatient-diaries-and-ecoa-market/toc 

However there are some restraints that are limiting the growth of the global market. As these technologies require internet connectivity to work perfectly, there are severe limitations in the scope of use. Also, in many places people are not much aware about these advanced technologies and clinics are faced with the issue of finding skilled professionals with the required technical know-how.

Report overview @ https://www.persistencemarketresearch.com/market-research/epro-epatient-diaries-and-ecoa-market.asp 

Global ePRO, E-Patient Diaries and eCOA Market: Segmental Highlights

This research report has systematically bifurcated the market into different segments thereby simplifying the analysis of the global ePRO, e-patient diaries and eCOA market. The segmentation is done on the basis of type of solution, end user, modality type, and region.

The regional markets analyzed in the report include North America, Latin America, Europe, APAC and MEA. Among these, North America is expected to dominate the global market in terms of value during the forecast period. However, Asia Pacific is projected to witness the highest CAGR of 16.6% during the study period.

Request to sample report @ https://www.persistencemarketresearch.com/samples/11506 

In terms of solution type, the market is dominated by the eCOA segment with a market valuation of just under US$ 636 Mn in 2017. The e-patient diaries segment is expected to hold a market value of about US$ 323 Mn in 2017.

On the basis of modality type, the market is dominated by the mobile devices segment, which is expected to reach a market value of around US$ 1,578 Mn by the end of 2025.

Clinical trial sponsors segment dominates the segments on the basis of end user. This segment is expected to grow at a CAGR of 16.2% during the forecast period.

There are a lot of new entrants in the business as well as some top companies already ruling the global market for ePRO, e-patient diaries and eCOA. Some of the key players mentioned in the report are Bracket Global LLC, Parexel International Corporation, Kayentis, SAS, Medidata Solutions, Inc., ArisGlobal LLC, CRF Health, ERT Clinical, and ICON plc.

Get full report now @ https://www.persistencemarketresearch.com/checkout/11506 

Operating Tables Market To Garner US$ 1,150 Million  By The End Of 2025

There have been several innovations in operation theater equipment globally and hospitals across the world can be seen demanding advanced operating tables to enhance the efficacy of the surgical process. Through a new report titled ‘Operating Tables Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,’ Persistence Market Research aims to track the performance of the global operating tables market and presents key insights on the factors impacting revenue growth of the global market over an eight year forecast period from 2017 to 2025. According to the report estimations, the global operating tables market is estimated to reach a market valuation of just under US$ 850 Mn by 2017 end, and this is projected to increase to a little more than US$ 1,150 Mn by the end of the forecast period in 2025, registering a CAGR of 3.9% in terms of value.

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/market-research/operating-tables-market/toc 

The global operating tables market is segmented on the basis of Product Type into General Surgical Tables, Radiolucent Operating Tables, Specialty Surgery Tables (Orthopedic Surgery Tables, Laparoscopic Operating Tables, Neurosurgical Operation Tables, Bariatric Surgery Tables), and Pediatric Operating Tables. General Surgical Tables is the largest segment, estimated to represent US$ 499.7 Mn, or 58.8% share of the global market in 2017 and is projected to reach US$ 654.5 Mn, or 56.6% share of the global market by 2025 end, expanding at a CAGR of 3.4% over the forecast period. This is the dominant product type as well as the most attractive market, registering an attractiveness index of 2.1 during the forecast period.

Report overview @ https://www.persistencemarketresearch.com/market-research/operating-tables-market.asp 

The global operating tables market is segmented on the basis of Technology into Powered Operating Tables, Non-powered/Manual Operating Tables, and Hybrid Operating Tables. Non-powered/Manual Operating Tables is the largest segment, estimated to represent US$ 423.4 Mn, or 49.8% share of the global market in 2017, growing at a CAGR of 3.7% over the forecast period.

The global operating tables market is segmented on the basis of End User into Hospitals, Clinics, and Ambulatory Surgical Centers. Hospitals is the largest segment with a market valuation projected to reach US$ 729.0 Mn by the end of 2025. However, Clinics is the fastest growing segment, registering the highest segmental CAGR of 4.7% in terms of value during the period of assessment.

Request to sample report @ https://www.persistencemarketresearch.com/samples/3789 

Persistence Market Research tracks the performance of the global operating tables market across the key geographies of North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. There is close competition among North America and Asia Pacific in terms of market value, with North America projected to reach a market valuation of US$ 363.6 Mn and Asia Pacific anticipated to be valued at US$ 370.0 Mn by the end of 2025. However, Asia Pacific is the fastest regional market, witnessing a growth rate of 4.8% during the period of study. Asia Pacific is projected to be the most attractive regional market with an attractiveness index of 1.9 during the forecast period.

The report features some of the top companies in the global operating tables market including the likes of STERIS plc, Skytron LLC, Siemens Medical Solutions USA, Inc., Stryker Corporation, Alvo Medical, Mizuho OSI, Getinge-Maquet, Germany Holding GmbH, Schaerer Medical USA, Inc., OPT Surgisystems S.R.L, NUVO, Inc., Hill-Rom Holdings Inc., Medifa GmbH & Co. KG, Allengers Medical Systems Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., BRUMABA GmbH & Co KG, AGA Sanitaetsartikel GmbH, Lojer Group, Famed ?ywiec Sp. z o. o., Merivaara Corp., AMTAI Medical Equipment, Inc.

Get full report now @ https://www.persistencemarketresearch.com/checkout/3789 

Antibacterial Drugs Market To Reach US$51,447.6 Mn  By The End Of 2025

As competition grows strong in the global antibacterial drugs, the leading players are finding it more convenience to collaborate with rivals to expand their product offering as well regional footprint worldwide. In a new study, Transparency Market Research (TMR) has identified Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, Johnson and Johnson, Bristol Myers Squibb Company, Novartis Ag, and Allergen Plc as some of the most prominent enterprises operating in the global antibacterial drugs market. To gain a competitive edge, Pfizer signed an agreement with AstraZeneca in August 2016. This collaboration was intended to acquire the commercialization and development rights of late-stage small molecule anti-infective business. Besides this, the market witnessed several other partnerships, collaborations, and acquisitions aimed at catapulting businesses to the forefront of the global antibacterial drugs market.

Despite strategies toyed by businesses to gain traction, the subpar pace of growth is unlikely to change for the global antibacterial drugs market. According to TMR, the global market is likely to exhibit a CAGR of 1.5% between 2017 and 2025. Given the growth pace, the market is expected to reach US$51,447.6 mn by the end of 2025, from US$45,325.0 mn in 2016. While North America held dominance in the global antibacterial drugs market in 2016, TMR forecasts sluggish growth for the region through the forecast period. In terms of drug-class, the B-lactam segment led the market in 2016.

Browse Full Research Report: https://www.transparencymarketresearch.com/antibacterial-drugs-market.html

Antibacterial Drugs Market Witnesses Threat from Looming Patent Expiries

The rising population of aged people, escalating number of bacterial strains, which are multidrug resistant, and the rising demand for effective yet affordable antibacterial drugs will give the market considerable boost over the forecast period. In addition, TMR predicts the global antibacterial drugs market to gain significantly from the increasing incidence of infectious diseases. It is also likely to gain from the rising demand for innovative molecules. Despite the aforementioned growth prospects, the advent of genetic drugs for antibacterial activities threatens the overall market. The looming patent expiries are also identified as key factors restraining the market. Furthermore, the research and development activities conducted in the field is insufficient as per many experts. This could pose significant threat to the overall antibacterial drugs market in the coming years.

Opportunities Prevalent in Emerging Nations to Boost Growth in Near Future

In the coming years, the market is likely to gain from factors such as the improved efficacy, fewer side effects, and reduced time of action. In addition, opportunities prevalent across emerging nations will enable the global antibacterial drugs market stay afloat during the forecast period. According to TMR, the market will gain considerable traction in emerging nations such as India and China.

In the last few years, several synthesis inhibitors have gone off-patent, which has made TMR predict that several of the drugs under clinical trial could be approved in the coming years. The likelihood of benefiting from the commercialization of drug-resistant infections treatment is also rising. Despite the influx of novel protein synthesis inhibitors, vaccines will remain the class of drugs contributing the most revenue toward the global antibacterial drugs market. These factors will enable growth in the global antibacterial drugs market in the coming years.

Angiography Market to Register Substantial Expansion by 2025

Angiography is a procedure of diagnostic imaging to detect abnormalities of blood vessels. The X-ray image obtained by the angiography procedure is called as angiogram. In angiography, a special dye, also known as contrast medium, is injected in the body through a thin tube of plastic known as catheter. The dye makes the blood flowing through the blood vessels visible in the X-ray image. The procedure thus detects the abnormalities of blood vessels such as blockage, narrowing, inflammation, and bleeding inside the blood vessels. Angiography assists in angioplasty procedure, wherein a stent is inserted inside an artery when the narrowing of the artery is detected in the angiogram. Angiography is generally conducted by a radiologist or a trained medical professional who operates the X-ray machine. This procedure helps to diagnose disorders which are related to blood vessels and determine the treatment of these disorders.

Increasing prevalence of coronary heart diseases, and favorable reimbursement policies for the treatment of heart disorders are the major factors driving the growth of the angiography market during the forecast period. However, high cost of the procedure and fluctuating scenario regarding the upgradation of angiography devices are expected to restrict the growth of the market during the forecast period.

Browse Full Research Report: https://www.transparencymarketresearch.com/angiography-market.html

The global angiography market can be segmented on the basis of procedure type, application, product, end-user, and region. Based on the procedure type, the market is segmented into coronary angiography, cerebral angiography, renal angiography, pulmonary angiography, and others. The coronary angiography segment held a significant market share in 2016 owing to increasing awareness about congestive heart failure and rising demand for precise diagnostic imaging techniques for better diagnosis of the disease conditions. This segment is anticipated to continue to dominate the angiography market during the forecast period due to the introduction of advanced diagnostic techniques by key players operating in the global market. In terms of application, the market is segmented into congestive heart failure, coronary artery disorders, kidney disorders, and others. The coronary artery disorders segment accounted for a high market share in 2016 owing to favorable reimbursement policies by various private and public players and rising global geriatric population. Increase in public funding to improve the health care infrastructure in developing countries and rise in the prevalence of cardiovascular disorders worldwide are projected to drive the growth of coronary artery disorders and kidney disorders segments during the forecast period.

On the basis of product, the market is divided into angiography systems, catheters, incision closure devices, balloons, contrast media, and other accessories. The angiography systems segment captured a high market share in 2016 owing to its high cost. The segment is expected to continue to dominate the market during the forecast period due to increase in per capita expenditure of the population and launch of new products in the medical diagnostic field. Based on the end-user, the market is divided into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment held a significant market share in 2016 and is expected to continue to dominate the market during the forecast period owing to availability of trained and well-qualified health care professionals and technological advancements in diagnostic techniques.

Geographically, the market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 due to rising adoption rate of modern and novel medical imaging techniques. However, Asia Pacific is projected to expand at a high CAGR during the forecast period due to rising geriatric population and government participation for the improvement of the health care sector in India and Japan. Rising demand for efficient medical diagnostic techniques and increasing prevalence of coronary heart diseases are expected to propel the market growth in North America by 2025.

Prominent players operating in the global angiography market include GE Healthcare, St. Jude Medical, Inc., Abbott Laboratories, Shimadzu Corporation, Bayer Ag, Allengers, OSCOR Inc., Degania Silicone Ltd., and CathRx Ltd. among others.

Advanced Therapy Medicinal Products Market to Register Substantial Expansion by 2025

Advanced therapy medicinal products (ATMPs) are innovative therapies that are based on gene therapy, somatic cell therapy, and tissue-built products. ATMPs are drug products which leverage living cellular or active genetic materials to offer novel treatment modalities in a range of both acute and chronic diseases. These therapies are relied upon for vital medical advantages. The advanced therapies are revolutionary treatments for a number of diseases or injuries, such as skin in burns victims, Alzheimer's, cancer, or muscular dystrophy. It has huge potential for patients and the industry. ATMPs represent a quickly developing field of interest. Although the vast majority of the products are in an early stage of development, the consolidated trial stage and the possibility to cure serious incessant conditions indicate that ATMPs may achieve the market sooner than standard treatments. Targeted treatments have opened the path for new trial strategies from which ATMPs could profit to get early access. ATMPs are regulated and authorized for marketing by the European Medicines Agency (EMA) in the EU and the Food and Drug Administration (FDA) in the U.S, each of which have specific routes to market depending on the product’s legal categorization.

Based on the type of therapy, advanced therapy medicinal products (ATMPs) are classified as somatic cell therapy medicinal product (SCTMP), tissue engineered medicinal product (TEP), gene therapy medicinal product (GTMP), and combined ATMPs. Cell therapy products like cancer vaccines are growing at a faster rate than gene therapy like Glybera, Strimvelis, and tissue engineered medicinal products due to the number of products advancing in clinical phase development and more number of clinical trials in progress. In addition to regulatory oversight of clinical studies, such as immune-oncology study and technological advancement in genetic engineering tools like talen, RNAi etc. boosts the market of advanced therapy medicinal products. However, a range of issues from a lack of sustainable funding models to insufficient transparency and regulatory guidance for biopharmaceutical companies is still challenging the greater uptake of these innovative treatments.

Browse Full Research Report: https://www.transparencymarketresearch.com/advanced-therapy-medicinal-products-market.html

Geographically, the advanced therapy medicinal products market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the dominant share of the global market due to the presence of key players and the advancement in gene and cell therapy with medical support. Moreover, cellular and gene therapy-related research and development in the region continue to grow at a fast rate, with a number of products advancing in clinical development. In addition to regulatory oversight of clinical studies, the Center for Biologics Evaluation and Research provides proactive scientific and regulatory advice to medical researchers and manufacturers in the area of novel product development. In Europe in EU, regulatory framework for such products was established with the Regulation (EC) 1394/2007, which came into force on December 30, 2008. The regulation established the centralized marketing authorization procedure as the applicable route to authorize advanced therapies. Furthermore, it established a new committee within the European Medicines Agency (EMA), known as the Committee for Advanced Therapies (CAT) which is responsible for assessing the quality, safety, and efficacy of advanced therapies which helps to expand the market in the particular region. However, opportunities for the market are growing in Asia Pacific countries such as India, China, and Japan as the factors driving the market are favorable in these highly populated countries. This is attributed to rapid rise in health care infrastructure and high level of variable diseases like cancer. In the Middle East and African countries, the development of healthcare projects and the economy helps to drive the market for advanced therapy medicinal products.

Key players in the advanced therapy medicinal products (ATMPs) market are GSK, Uniqure, Kite Pharma, Pfizer, Adaptimmune, Bluebird Bio Inc., BioMarin Pharmaceutical, Novartis, GE Healthcare, and Shire Biotechnology.

Diabetes Devices Market To Reach US$66,053.1 Mn  By The End Of 2025

Transparency Market Research observes that the competitive landscape in the diabetes devices market is moderately consolidated. Some of the leading companies in this market are Medtronic plc, Eli Lilly and Company, Sanofi S.A., F. Hoffmann-La Roche Ltd, and Novo Nordisk A/S. Most of these companies are focusing on expanding their business in developing parts of the world to tap into the wide consumer base. Furthermore, developing and commercializing diabetes devices that are simple yet affordable will be a winning strategy of these players in the near future.

According to the research report, the global diabetes devices market is expected to be worth US$66,053.1 mn by the end of 2025 from US$37,220.8 mn in 2016. During the forecast period of 2017 and 2025, the global market is expected to rise at a CAGR of 6.7%. Out of the wide range of products to manage diabetes, the global market is likely to be driven by glucose monitoring devices and the products available under this segment. As of 2016, the blood glucose meters held a share of 59.1% in terms of revenue in the global market. Geographically, the global market is dominated by North America due to higher awareness about the disease.

Browse Full Research Report: https://www.transparencymarketresearch.com/diabetes-devices-market.html

The global diabetes devices market is primarily being driven by the soaring diagnostic rate of diabetes across the globe. The high occurrence of this disease is attributable to the highly sedentary lifestyles, excessive stressful living, poor dietary choices, and high alcohol consumption. The improving rate of diagnoses has also led to increased uptake of diabetes devices in recent years. Furthermore, affordable price of devices such as self-monitoring blood glucose meters, lancets, testing strips, and continuous monitoring devices are have also had a positive influence on the overall market. The analysts state the growing awareness about way to manage the disease better is also projected to spike the demand in the global market.

Rise in the number of diabetics due to occurrence of conditions such as jaundice, dengue, pregnancy, and old age has also created a spur in the demand of diabetes devices. Thus, a large pool of patients is projected to fuel market growth in the near future. Growing investments in developing better home diagnostic machines and efficient solutions are expected to generate greater revenues. Convenience of using these devices enabled by their simple design has also been identified as a key market growth for the global market. Thus, the ability to make a safer and effective diagnosis of diabetes is expected to benefit the vendors in the global market.

On the downside, the global market is being affected by the lack of awareness about diabetes and its management in the rural parts of the world. The poor rate of knowledge and low rate of inclination to treat the disease has created a major negative impact on the overall market. Furthermore, diabetes devices continue to be unaffordable to several patients in the low-income category. Thus, the relative high cost of these devices and treatment coupled with lack of reimbursement issues is likely to hamper the market growth.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

 Contact Us

Transparency Market Research

State Tower,

90 State Street, Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

Follicular Lymphoma Treatment Market to Register Substantial Expansion by 2025

Follicular lymphoma is the second most common sub-type of non-Hodgkin lymphoma (NHL), which accounts for more than 20% of all NHL cases. Follicular lymphoma is highly indolent. The most common sub-type of NHL is diffuse large B-cell lymphoma (DLBCL). Follicular lymphoma is referred to as cancer of the lymphatic system. The lymphatic system is a part of the body’s immune system. It comprises the spleen, the thymus, the lymph nodes, the tonsils, the lymph tissue, and the bone marrow. Cancerous growth of follicular lymphomas is slower than other sub-types of NHL. Follicular lymphoma primarily results in abnormal formation of B-lymphocytes in the lymph nodes. B-lymphocytes is a type of white blood cells and a key constituent of the human immune system. Major symptoms of follicular lymphoma include shortness of breath; fatigue; night sweats; weight loss; and enlargement of the lymph nodes in the neck, the groin, and the abdomen. According to the National Cancer Institute, NIH, the U.S., more than 72,000 people in the U.S. alone would be diagnosed with some form of NHL and more than 20,000 patients with NHL would die by the end of 2017. The follicular lymphoma disease can be diagnosed by using biopsy, radiology, blood tests, etc. Follicular lymphoma can be treated by using radiation therapy, chemotherapy, targeted therapy, and stem cell transplantation.

Some of the key factors that would drive the global follicular lymphoma treatment market in the near future are rising prevalence of follicular lymphoma, family history of the disease, and increasing incidence of blood disorders worldwide. In addition, increasing research and development activities for innovation of newer drugs and treatment methods and technological advancements in disease diagnosis would further fuel the follicular lymphoma market in the near future. However, strict regulatory requirements for drug approval, high treatment cost, and adverse effects associated with different treatment methods may restrain the market during the forecast period. Furthermore, a large number of promising pipeline drugs and newer therapies such as monoclonal antibodies along with government initiatives for cancer management are anticipated to boost the market during the forecast period.

Browse Full Research Report: https://www.transparencymarketresearch.com/follicular-lymphoma-treatment-market.html

The follicular lymphoma treatment market can be segmented based on treatment type, route of administration, end-user/distribution channel, and geography. Based on treatment type, the market can be segmented into chemotherapy, targeted therapy, radiotherapy, monoclonal antibodies, and stem cell transplantation. The chemotherapy segment can be sub-segmented into alkylating agents, nucleoside analogues, anthracycline derivatives, and others. Based on route of administration, the follicular lymphoma treatment market can be segmented into oral, parenteral, and others. Based on end-user/distribution channel, the market can be divided into hospitals, retail pharmacies, oncology centers, and academic & research institutes.

Geographically, the global follicular lymphoma treatment market can be segmented into five regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America follicular lymphoma treatment market is poised to witness significant growth during the forecast period, as a few recent surveys have estimated high growth in the prevalence of the disease in the region, especially in the U.S., in the near future. Current trends observed in pipeline drugs for the treatment of follicular lymphoma also indicate high growth opportunities for the North America follicular lymphoma treatment market. The market in Europe is also anticipated to expand significantly during the forecast period, due to well-established health care infrastructure and increase in the prevalence of follicular lymphoma in the region. Other regions such as Asia Pacific, Latin America, and Middle East & Africa present lucrative opportunities for growth of the follicular lymphoma treatment market, owing to large patient pool in these regions, growing awareness about the disease, and availability of options for its management.

Some of the key players operating in the global follicular lymphoma treatment market are AbbVie, Inc., Bayer AG, Bristol Myers Squibb and Company, Epizyme Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline plc, Johnson and Johnson Services, Inc., Merck & Co. Inc., and Novartis AG.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Phosphate Binding Agents Market to Register Substantial Expansion by 2025

Cardiovascular diseases and diabetes lead to common complications such as nephrology and urology disorders. Unhealthy food habits and drugs are known to cause nephrological and urological diseases. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 26 million people have chronic kidney diseases in the U.S. The statistics show that about 87,000 patients die due to kidney failure every year. Commonly used drug classes for treating nephrological and urological disorders include diuretics, anti-hypertensive drugs, phosphate binders, and anti-cholinergic and 5-alpha-reductase inhibitors. Phosphate binders are drugs which are used to lower the absorption of phosphate in patients suffering from chronic renal failure due to their inability to remove phosphorus naturally. Excess deposition of phosphorus in the body, especially in a kidney failure patient, results in the depletion of calcium from bones and ultimately leads to diseases such as hyperphosphatemia and renal osteodystrophy or renal bone. Phosphate binders work by binding phosphate in the gastrointestinal tract, ultimately making it unavailable to the body for absorption. In June 2014, Keryx Biopharmaceuticals, Inc. received patent for Zerenex, a ferric citrate based phosphate binder, which will expire in 2024. The company has filed new drug application (NDA) for Zerenex and is currently under review by the U.S. FDA. Sanofi lost patent for Renvela (sevelamer) in 2014; the drug generated a total revenue of US$ 750 Mn in 2013. Other key drugs in the market include Alucap (aluminum hydroxide) by Meda Pharma, Calcichew (calcium carbonate), Renagel (sevelamer) by Genzyme Corporation, and Fosrenol (lanthanum carbonate) by Shire US, Inc.

The rising prevalence of chronic kidney diseases is a major factor driving the growth of the global phosphate binding agents market. For instance, over 20 million people in America are affected by chronic kidney diseases; the incidence rate of these diseases is rapidly growing among people above the age of 65 years. The FDA has approved the use of these phosphate binding agents in hyperphosphatemia secondary to chronic kidney diseases. In addition, rising awareness about the complications caused due to chronic kidney diseases and the treatment options is fueling the growth of the global market. However, phosphate binding agents have certain gastrointestinal reactions such as diarrhea, nausea, vomiting, and abdominal pain, leading to their discontinuation. This factor is restraining the growth of the market for phosphate binding agents.

Browse Full Research Report: https://www.transparencymarketresearch.com/phosphate-binding-agents-market.html

The global phosphate binding agents market has been segmented based on type, application, distribution channel, and region. In terms of type, the market is segmented as calcium-based phosphorus binders; aluminum-free, calcium-free phosphorus binders; aluminum-based phosphorus binders; and magnesium-based phosphorus binders. The calcium-based phosphorus binders segment primarily includes calcium carbonate and calcium acetate. These calcium-based phosphorous binders have largely replaced aluminum-based phosphorous binders, and these binders also serve as calcium supplements. In terms of application, the market is segmented as hyperphosphatemia, hyperphosphatemia of renal failure, osteodystrophy, and anemia. In terms of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online retailers, and private clinics.

Geographically, the global phosphate binding agents market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the largest market share owing to high research and development, favorable reimbursement policies, and availability of advanced health care infrastructure. The implementation of the Affordable Care Act has significantly posed limitations to hospitals as well as pharmaceutical companies with respect to costing of new drugs. Europe is the second largest market for phosphate binding agents due to presence of high quality scientific companies and research organizations. However, lack of proper reimbursement policies and regulatory framework pertaining to new drug development could restraint the growth of the Europe market during the forecast period.

Key players operating in the global market include Shire US, Inc., Meda Pharma, and Genzyme Corporation.

Glycated Hemoglobin Testing Market To Reach US$ 705 Mn  By The End Of 2026

Increasing incidences of diabetes have propelled the need for improved diagnostics in the global healthcare devices. Companies manufacturing critical diagnostic devices are focusing on facilitating products for effective tests. The use of glycated hemoglobin in diagnosis of diabetes mellitus continues to gain traction, creating a steady demand for glycated hemoglobin testing. Transparency Market Research’s recent report on the global glycated hemoglobin testing market delivers a forecast outlook on growing demand for these tests in diagnosis of prevalent disorders such as diabetes.

According to the report, the global market for glycated hemoglobin testing is expected to be worth US$ 705 Mn by the end of 2026. During the forecast period, 2017-2026, the global glycated hemoglobin testing market is expected to expand at a CAGR of 8.8%. Leading manufacturers of medical devices are anticipated to be key participants in the global expansion of the glycated hemoglobin testing market. Companies namely, Siemens Healthcare, Bio-Rad Laboratories, Arkray, Ceragem Medisys, Bayer, Chek Diagnostics, DiaSys Diagnostic Systems, Daiichi Biotech, Diazyme Laboratories, Erba Mannheim, EKF Diagnostics, Human Diagnostics, Menarini, Lite-On Technology, Mindray Medical, TaiDoc Technology, Sebia, Randox Laboratories, Trinity Biotech, and Tosoh Bioscience are expected to be observed as leading manufacturers of devices used in glycated hemoglobin tests.

Browse Full Research Report: https://www.transparencymarketresearch.com/glycated-hemoglobin-testing-market.html

Key findings from the report reveal that the global market for glycated hemoglobin testing will witness a significant traction in demand for laboratory based tests. While patients are actively opting for point-of-care glycated hemoglobin testing, laboratories continue to be the key medium where these tests can be executed effectively. In 2017, more than US$ 240 Mn worth of revenues are anticipated to be procured in the global glycated hemoglobin testing market from laboratory based tests. The study also projects that by the end of 2026, point-of-care glycated hemoglobin tests will account for over one-fourth revenue share of the global market.

A regional analysis on the global glycated hemoglobin testing market has been provided in the report. Increasing presence of diabetics in the US and Canada has been observed as the governing factors for fuelling the growth of the glycated hemoglobin testing market in North America. In the overall glycated hemoglobin testing market, North America is expected to dominate in terms of global revenue share. In 2017, the glycated hemoglobin testing market in North America is estimated to be worth over US$ 110 Mn. Meanwhile, the demand for these tests is also expected to gain traction in Europe and the Asia-Pacific excluding Japan (APEJ) region. Improving healthcare infrastructure and diabetic dietary lifestyles of consumers in these regions are observed as the superficial factors driving the growth of glycated hemoglobin testing market in Europe and the APEJ region.

On the basis of techniques, glycated hemoglobin tests can be carried out through immunoassays and chromatography, among others. In 2017, the sales of devices in the global glycated hemoglobin testing market for chromatography and immunoassay techniques are estimated to showcase near-equal revenue share. Moreover, the use of these techniques will depend largely upon the end-use of glycated hemoglobin tests. Hospitals are anticipated to emerge as the largest end-users in the global glycated hemoglobin testing market. In terms of revenues, the end-use of glycated hemoglobin testing in hospitals is expected to rake in US$ 275 Mn globally by the end of 2026. Diagnostic centers are also estimated to emerge as leading end-users of glycated hemoglobin testing in the global market.

Advanced Therapy Medicinal Products Market Estimated to Bring US$78.54 Bn by 2025

Advanced therapy medicinal products (ATMPs) are innovative therapies that are based on gene therapy, somatic cell therapy, and tissue-built products. ATMPs are drug products which leverage living cellular or active genetic materials to offer novel treatment modalities in a range of both acute and chronic diseases. These therapies are relied upon for vital medical advantages. The advanced therapies are revolutionary treatments for a number of diseases or injuries, such as skin in burns victims, Alzheimer's, cancer, or muscular dystrophy. It has huge potential for patients and the industry. ATMPs represent a quickly developing field of interest. Although the vast majority of the products are in an early stage of development, the consolidated trial stage and the possibility to cure serious incessant conditions indicate that ATMPs may achieve the market sooner than standard treatments. Targeted treatments have opened the path for new trial strategies from which ATMPs could profit to get early access. ATMPs are regulated and authorized for marketing by the European Medicines Agency (EMA) in the EU and the Food and Drug Administration (FDA) in the U.S, each of which have specific routes to market depending on the product’s legal categorization.

Based on the type of therapy, advanced therapy medicinal products (ATMPs) are classified as somatic cell therapy medicinal product (SCTMP), tissue engineered medicinal product (TEP), gene therapy medicinal product (GTMP), and combined ATMPs. Cell therapy products like cancer vaccines are growing at a faster rate than gene therapy like Glybera, Strimvelis, and tissue engineered medicinal products due to the number of products advancing in clinical phase development and more number of clinical trials in progress. In addition to regulatory oversight of clinical studies, such as immune-oncology study and technological advancement in genetic engineering tools like talen, RNAi etc. boosts the market of advanced therapy medicinal products. However, a range of issues from a lack of sustainable funding models to insufficient transparency and regulatory guidance for biopharmaceutical companies is still challenging the greater uptake of these innovative treatments.

Browse Full Research Report: https://www.transparencymarketresearch.com/advanced-therapy-medicinal-products-market.html

Geographically, the advanced therapy medicinal products market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the dominant share of the global market due to the presence of key players and the advancement in gene and cell therapy with medical support. Moreover, cellular and gene therapy-related research and development in the region continue to grow at a fast rate, with a number of products advancing in clinical development. In addition to regulatory oversight of clinical studies, the Center for Biologics Evaluation and Research provides proactive scientific and regulatory advice to medical researchers and manufacturers in the area of novel product development. In Europe in EU, regulatory framework for such products was established with the Regulation (EC) 1394/2007, which came into force on December 30, 2008. The regulation established the centralized marketing authorization procedure as the applicable route to authorize advanced therapies. Furthermore, it established a new committee within the European Medicines Agency (EMA), known as the Committee for Advanced Therapies (CAT) which is responsible for assessing the quality, safety, and efficacy of advanced therapies which helps to expand the market in the particular region. However, opportunities for the market are growing in Asia Pacific countries such as India, China, and Japan as the factors driving the market are favorable in these highly populated countries. This is attributed to rapid rise in health care infrastructure and high level of variable diseases like cancer. In the Middle East and African countries, the development of healthcare projects and the economy helps to drive the market for advanced therapy medicinal products.

Key players in the advanced therapy medicinal products (ATMPs) market are GSK, Uniqure, Kite Pharma, Pfizer, Adaptimmune, Bluebird Bio Inc., BioMarin Pharmaceutical, Novartis, GE Healthcare, and Shire Biotechnology.

Wound Treatment Market to Reach a whopping US$78.54 Bn by 2020

The global wound treatment market includes an array of products, each formulated to avoid an infection in a wound and heal it. Wounds are generally classified as acute or chronic. The global wound treatment market is categorized into the following segments: advanced, basic, bioactive, therapeutic, and traditional devices. The advanced wound treatment market can be further divided into hydrogels, foam wound care, moist wound care, alginates, hydrocolloid and hydrogels. Advanced wound treatment is budding as a regular way out for treating chronic wounds. Traditional wound treatment is being increasingly replaced with advanced wound treatment due to their better effectiveness and efficacy in treating wounds by allowing faster healing.

The global wound treatment market is driven by a variety of factors such as privileged incidences of hospital-acquired infections, rising aging population, increasing diabetic and obese population, government spending for advancement of wound treatment products, new materials used for product innovation and development in chemical and biological sciences resulting in growth of the market. The requirement for portable and easy to use devices is likely to drive the growth of wound treatment market. On the other hand, factors such as high costs of advanced wound treatment products and competiveness may inhibit the growth of these products in the global wound treatment market.

Browse Full Research Report: https://www.transparencymarketresearch.com/wound-treatment-market.html

Geographically, the global wound treatment market is segmented into North America, Europe, Asia Pacific and Rest of the World. Asia Pacific is expected to grow rapidly, due to rising incidences of chronic diseases, increasing aging population, rising awareness for wound treatment products, and increasing population with pressure ulcers has enhanced the demand for wound treatment products. With respect to the advance wound treatment products the Asian market is predictable to observe moderate growth, due to forcing physicians and patients to choose for traditional treatment, and lack of reimbursement.

 In addition, majority of the players are focusing on the Asian market. For example, in 2012, Smith & Nephew launched 23 new wound treatment products (such as single use Negative Pressure Wound Therapy (NPWT) system, pocket-sized PICO system) in the Asian markets. Also, in December 2012, ConvaTec India Private Limited started its operations in Bangalore, Karnataka, India, to convey new healthcare products, technologies, and healing treatment to the Indian market, thus establishing its trail in the Asian market. Such expansion is expected to drive the Asian wound care market in the upcoming years.

Some of the key global market participants present in the global wound treatment market includes Smith & Nephew plc, Baxter International, Inc., Ethicon, Inc., 3M Company, Covidien PLC, Derma Sciences, Inc., Coloplast A/S, Hollister, Inc., Convatec Healthcare B.S.A.R.L., Mölnlycke Health Care , Kinetic Concept, Inc and others.

Blood Processing Devices and Consumables Market Estimated to Bring US$49.1 Bn by 2019

A new Transparency Market Research report states that the blood processing devices and consumables market stood at US$27.2 bn in 2012 and is predicted to reach US$49.1 bn by 2019. It is expected to expand at a CAGR of 8.90% from 2013 to 2019. The title of the report is “Blood Processing Devices and Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”.

According to the report, the blood processing devices and consumables market is stimulated by the rising demand for blood products due to the increasing global aging population and the rise in complex surgical procedures such as orthopedic and open heart surgeries. In addition, the market will also expand owing to the launch of cutting-edge products and technological advancements. In addition, favorable reimbursement policies will also impact the market positively. On the other hand, the soaring costs of blood handling equipment will impede the growth of the market in the coming years.

Browse Full Research Report: https://www.transparencymarketresearch.com/blood-processing-market.html

Among blood processing devices, the blood processing devices and consumables market is segmented into blood band freezers, blood bank refrigerators, blood warmers, blood group analyzers, blood cell processors, and hematocrit centrifuges. In terms of consumables, the market is segmented into blood lancets, blood administration sets, vials, blood filters, microscopic slides, test tube racks, coagulation reagents, slide strainers, blood grouping reagents, blood bags, blood collection tubes, blood collection needles, sedimentation tubes, and hematology reagents. Amongst these, automated devices including automated cell processor devices and whole blood collection devices represented a bigger share in comparison to manual blood processing and collection methods. This is because processing and collection done via automated devices increases operational efficiency. On the other hand, the multispecialty blood bags market is predicted to rise exponentially in the coming years as blood bags ensure sterility during transfusion and have replaced the traditional method of utilizing glass bottles during the transfusion procedure.

On the basis of geography, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). Amongst these, North America leads the market due to it being a developed region, rising public awareness, and increasing support by governments in this region. On the other hand, Asia Pacific is also a lucrative market for blood processing devices and consumables owing to its rising population base and increasing demand for blood components and blood. In addition, the increasing demand for safe transfusion and blood collection procedures in this region will also create promising opportunities for suppliers in this region, thus raising the demand for blood processing devices and consumables.

As per this report, there has been high competition in the market amongst the prime players and this market is highly fragmented in nature. The key players dominant in the market are MacoPharma SA, Terumo BCT, Fresenius Kabi AG, Immucor, Inc., Haemonetics Corporation, and others, as stated in this report.